GlassScriptPhysician profile
Patricia M Gale
NPI 1437119229
$2,914.78
in general payments reported to CMS, 2019-2025
28 companies · $301 in 2025
The $301 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $533 · 2020: $120 · 2021: $463 · 2022: $869 · 2023: $417 · 2024: $210 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $928.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,122.26 | 2019-2025 | |
| Organon LLC | $216.47 | 2021-2025 | Nexplanon, Jada System |
| Avion Pharmaceuticals | $182.78 | 2021-2023 | Balcoltra |
| Mayne Pharma Commercial LLC | $143.94 | 2022-2025 | |
| Coopersurgical, INC. | $131.43 | 2019-2025 | Paragard T 380a |
| Mylan Pharmaceuticals INC. | $113.52 | 2021-2022 | |
| Pfizer INC. | $93.86 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $86.37 | 2019-2024 | Gardasil 9, Gardasil |
| Bayer Healthcare Pharmaceuticals INC. | $86.35 | 2019-2025 | |
| Allergan, INC. | $69.49 | 2019-2020 | |
| Agile Therapeutics, INC. | $69.24 | 2021-2024 | Twirla |
| Hologic Sales and Service, LLC | $68.16 | 2022-2025 | Aptima, Myosure Tissue Removal Device |
| Roche Diagnostics Corporation | $68.09 | 2019 | |
| Therapeuticsmd, INC. | $52.58 | 2019 | |
| Myovant Sciences INC. | $49.34 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $48.30 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $37.51 | 2019 | |
| Amgen INC. | $37.15 | 2024 | Prolia, Evenity |
| Lupin INC. | $32.60 | 2019 | |
| Vertical Pharmaceuticals, LLC | $31.31 | 2019 | |
| Sumitomo Pharma America, INC. | $26.93 | 2023 | Myfembree |
| Exact Sciences Corporation | $25.98 | 2024 | Cologuard Collection Kit |
| Dysis Medical, INC. | $25.42 | 2022 | |
| Becton, Dickinson and Company | $24.16 | 2022 | |
| Biogen, INC. | $23.32 | 2025 | Zurzuvae |
| Channel Medsystems, INC. | $19.48 | 2022 | |
| Exeltis, USA INC. | $17.41 | 2021 | |
| Mission Pharmacal Company | $11.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Gale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.